Dr. Reddy's Laboratories had a closing cash flow value of 14.85 billion Indian rupees at the end of fiscal year 2023. This was valued at 14.82 billion rupees at the end of the previous fiscal year, marking lower expenses. Dr. Reddy's is one of the biggest Indian multinational pharmaceutical companies based in the southern city of Hyderabad.
Cash flow of Dr. Reddy's Laboratories Limited from financial year 2018 to 2023, by type (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
Selected statistics
9
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Basic Statistic Pharmaceutical industry: the cost of introducing a new product 1970-2010s
- Basic Statistic producer price index of chemical and pharmaceutical products in Norway 2008-2022
- Basic Statistic Value of generic pharmaceutical market in Turkey 2010-2022
- Basic Statistic Value of pharmaceutical sales in Belgium 2004-2022
- Basic Statistic Rx drugs by type used widely by older Americans 2017
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2022
- Premium Statistic Number of pharmaceutical manufacturing companies Philippines 2006 & 2012, by region
- Basic Statistic Value of pharmaceutical sales in Latvia 2003-2022
- Basic Statistic Value of pharmaceutical sales in Slovenia 2010-2022
- Basic Statistic Value of pharmaceutical sales in Luxembourg 2003-2022
Related statistics
10
- Premium Statistic Sun Pharma's income FY 2010-2022
- Premium Statistic Sun Pharma's profit after tax FY 2014-2022
- Premium Statistic Net profit of major pharma companies India 2022
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Indian pharmaceutical export value FY 2012-2023
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Growth rate of top therapies in Indian pharmaceuticals 2022
Further related statistics
6
- Pfizer's ad spending 2008-2022
- Foreign exchange earnings from tourism in India 2000-2021
- International tourism receipts of India 2011-2021
- Number of international tourist arrivals in India 2010-2021
- Per capita consumer spending in India 1974-2012
- Number of patients with non-communicable diseases in India 2010
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- Foreign exchange earnings from tourism in India 2000-2021
- International tourism receipts of India 2011-2021
- Number of international tourist arrivals in India 2010-2021
- Per capita consumer spending in India 1974-2012
- Number of patients with non-communicable diseases in India 2010
Dr. Reddy's Laboratories. (July 1, 2023). Cash flow of Dr. Reddy's Laboratories Limited from financial year 2018 to 2023, by type (in billion Indian rupees) [Graph]. In Statista. Retrieved September 24, 2023, from https://www.statista.com/statistics/991336/india-drreddy-s-laboratories-cash-flow-by-type/
Dr. Reddy's Laboratories. "Cash flow of Dr. Reddy's Laboratories Limited from financial year 2018 to 2023, by type (in billion Indian rupees)." Chart. July 1, 2023. Statista. Accessed September 24, 2023. https://www.statista.com/statistics/991336/india-drreddy-s-laboratories-cash-flow-by-type/
Dr. Reddy's Laboratories. (2023). Cash flow of Dr. Reddy's Laboratories Limited from financial year 2018 to 2023, by type (in billion Indian rupees). Statista. Statista Inc.. Accessed: September 24, 2023. https://www.statista.com/statistics/991336/india-drreddy-s-laboratories-cash-flow-by-type/
Dr. Reddy's Laboratories. "Cash Flow of Dr. Reddy's Laboratories Limited from Financial Year 2018 to 2023, by Type (in Billion Indian Rupees)." Statista, Statista Inc., 1 Jul 2023, https://www.statista.com/statistics/991336/india-drreddy-s-laboratories-cash-flow-by-type/
Dr. Reddy's Laboratories, Cash flow of Dr. Reddy's Laboratories Limited from financial year 2018 to 2023, by type (in billion Indian rupees) Statista, https://www.statista.com/statistics/991336/india-drreddy-s-laboratories-cash-flow-by-type/ (last visited September 24, 2023)
Cash flow of Dr. Reddy's Laboratories Limited from financial year 2018 to 2023, by type (in billion Indian rupees) [Graph], Dr. Reddy's Laboratories, July 1, 2023. [Online]. Available: https://www.statista.com/statistics/991336/india-drreddy-s-laboratories-cash-flow-by-type/